Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 3
1985 5
1986 4
1988 3
1989 5
1990 2
1991 3
1992 6
1993 4
1994 1
1995 6
1996 3
1997 4
1998 4
1999 11
2000 4
2001 2
2002 2
2003 8
2004 5
2005 4
2006 9
2007 6
2008 5
2009 9
2010 6
2011 6
2012 6
2013 6
2014 10
2015 3
2016 8
2017 4
2018 5
2019 3
2020 5
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

182 results
Results by year
Filters applied: . Clear all
Page 1
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
Menzies-Gow A, Colice G, Griffiths JM, Almqvist G, Ponnarambil S, Kaur P, Ruberto G, Bowen K, Hellqvist Å, Mo M, Garcia Gil E. Menzies-Gow A, et al. Among authors: colice g. Respir Res. 2020 Oct 13;21(1):266. doi: 10.1186/s12931-020-01526-6. Respir Res. 2020. PMID: 33050934 Free PMC article.
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
Wechsler ME, Colice G, Griffiths JM, Almqvist G, Skärby T, Piechowiak T, Kaur P, Bowen K, Hellqvist Å, Mo M, Garcia Gil E. Wechsler ME, et al. Among authors: colice g. Respir Res. 2020 Oct 13;21(1):264. doi: 10.1186/s12931-020-01503-z. Respir Res. 2020. PMID: 33050928 Free PMC article.
DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
Menzies-Gow A, Ponnarambil S, Downie J, Bowen K, Hellqvist Å, Colice G. Menzies-Gow A, et al. Among authors: colice g. Respir Res. 2020 Oct 21;21(1):279. doi: 10.1186/s12931-020-01541-7. Respir Res. 2020. PMID: 33087119 Free PMC article.
Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2.
Popovic B, Breed J, Rees DG, Gardener MJ, Vinall LM, Kemp B, Spooner J, Keen J, Minter R, Uddin F, Colice G, Wilkinson T, Vaughan T, May RD. Popovic B, et al. Among authors: colice g. J Mol Biol. 2017 Jan 20;429(2):208-219. doi: 10.1016/j.jmb.2016.12.005. Epub 2016 Dec 9. J Mol Biol. 2017. PMID: 27956146 Free article.
Reply.
van Aalderen WM, Grigg J, Guilbert TW, Roche N, Colice G, Postma DS, Hillyer EV, Price DB. van Aalderen WM, et al. Among authors: colice g. J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):372-3. doi: 10.1016/j.jaip.2015.12.006. J Allergy Clin Immunol Pract. 2016. PMID: 26968965 No abstract available.
Response.
Colice GL, Idell S. Colice GL, et al. Chest. 2014 Sep;146(3):e104-e105. doi: 10.1378/chest.14-0920. Chest. 2014. PMID: 25180733 Free PMC article. No abstract available.
182 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page